• 대한생식의학회:학술대회논문집
• /
• 2006.06a
• /
• pp.164.2-164.2
• /
• 2006

• 대한생식의학회:학술대회논문집
• /
• 2007.06a
• /
• pp.148-148
• /
• 2007

• 대한생식의학회:학술대회논문집
• /
• 2006.06a
• /
• pp.174.1-174.1
• /
• 2006

• 대한생식의학회:학술대회논문집
• /
• 2002.05a
• /
• pp.67-67
• /
• 2002

• 대한생식의학회:학술대회논문집
• /
• 2003.12a
• /
• pp.132-133
• /
• 2003

• 대한생식의학회:학술대회논문집
• /
• 2003.12a
• /
• pp.115-116
• /
• 2003

• Clinical and Experimental Reproductive Medicine
• /
• v.44 no.4
• /
• pp.159-170
• /
• 2017

The development of biomarkers of reproductive medicine is still in its infancy because many black boxes are still present in reproductive medicine. Novel approaches to human infertility diagnostics and treatment must be developed because reproductive medicine has lagged behind in the implementation of biomarkers in clinical medicine. Despite the dearth of the available literature, the current rapid pace of publications suggests that this gap will soon be filled therefore; this review is a $pr\acute{e}cis$ of the research that has been done so far and will provide a basis for the development of biomarkers in reproductive medicine.

• Proceedings of the Korean Society of Embryo Transfer Conference
• /
• 2004.10a
• /
• pp.116-116
• /
• 2004

• 대한생식의학회:학술대회논문집
• /
• 2007.06a
• /
• pp.147-147
• /
• 2007

• 대한생식의학회:학술대회논문집
• /
• 2004.11a
• /
• pp.94-94
• /
• 2004